featured
Increased pCR With Addition of Capecitabine to Epirubicin/Docetaxel in Neoadjuvant Treatment of Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Epirubicin and Docetaxel With or Without Capecitabine as Neoadjuvant Treatment for Early Breast Cancer: Final Results of a Randomized Phase III Study (ABCSG-24)
Ann. Oncol 2013 Dec 16;[EPub Ahead of Print], GG Steger, R Greil, A Lang, M Rudas, F Fitzal, B Mlineritsch, BL Hartmann, R Bartsch, E Melbinger, M Hubalek, H Stoeger, P Dubsky, S Ressler, AL Petzer, CF Singer, C Muss, R Jakesz, SP Gampenrieder, CC Zielinski, C Fesl, M GnantFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.